期刊文献+

糖尿病性心血管自主神经病变研究的进展 被引量:1

Research progress of diabetic cardiovascular autonomic neuropathy
下载PDF
导出
摘要 糖尿病心血管自主神经病变(DCAN)是一种以心血管系统自主神经控制受损为特征的慢性糖尿病并发症,糖尿病患者DCAN发生率较高。由于DCAN症状体征均不显著,临床对此并发症认识不足,常常延误诊治,导致心律失常、隐性心肌梗死甚至猝死的发生率升高。本文就DCAN的发病机制、临床表现、诊断及治疗方案作一综述,旨在为DCAN的治疗提供思路。 Diabetic cardiovascular autonomic neuropathy(DCAN)is a chronic diabetic complication characterized by impaired autonomic control of cardiovascular system.Incidence rate of DCAN is higher in patients with diabetes mellitus.Because symptoms and signs of DCAN are not significant,clinical understanding of this complication is insufficient,and diagnosis and treatment are often delayed,leading to elevated incidence rate of arrhythmia,occult myocardial infarction and even sudden death.The present article makes a review on pathogenesis,clinical manifestations,diagnosis and therapeutic program of DCAN,aiming at providing thinking for DCAN treatment.
作者 李娜 宋海燕 LI Na;SONG Hai-yan(Department of Endocrinology,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)
出处 《心血管康复医学杂志》 CAS 2021年第5期622-625,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 国家自然科学基金(81370903)。
关键词 心血管疾病 糖尿神经病变 心肌梗死 Cardiovascular Diseases Diabetic Neuropathies,Myocardial Infarction
  • 相关文献

参考文献10

二级参考文献214

  • 1易忠,张萍.动态心电图应用进展——第二届全国动态心电图临床应用研讨会纵观[J].临床心电学杂志,2005,14(4):235-242. 被引量:7
  • 2王玉,任艳,宋晓红.有氧运动对糖尿病患者心率变异的影响[J].中国运动医学杂志,2006,25(4):404-406. 被引量:11
  • 3杨秋萍,张溪,韩睿,李力,宋滇平.肥胖程度对心率变异性的影响[J].中国临床康复,2006,10(48):25-27. 被引量:8
  • 4杨秋萍,张溪,吴于滨,牛玲,宋滇平.腰围与心率变异性相关性分析[J].中国糖尿病杂志,2007,15(7):424-425. 被引量:1
  • 5Goto Y,Hotta N? Shigeta Y, et al. Effects of an aldose reduc-tase inhibitor, epalrestat, on diabetic neuropathy. Clinical ben-efit and indication for the drug assessed from the results of aplacebo-controlled double-blind study. Biomed Pharmacother,1995, 49 r 269-277. 被引量:1
  • 6Hotta N,Akanuma Y,Kawamori R, et al. Long-term clinicaleffects of epalrestat, an aldose reductase inhibitor, on diabeticperipheral neuropathy: the 3-year, multicenter, comparativeAldose Reductase Inhibitor^Diabetes Complications Trial. Dia-betes Care, 2006, 29:1538-1544. 被引量:1
  • 7Ikeda T, Iwata K,Tanaka Y. Long-term effect of epalrestaton cardiac autonomic neuropathy in subjects with non-insulindependent diabetes mellitus. Diabetes Res Clin Pract, 1999,43:193-198. 被引量:1
  • 8Nakayama M, Nakamura J, Hamada Y, et al. Aldose reduc-tase inhibition ameliorates pupillary light reflex and F-wave la-tency in patients with mild diabetic neuropathy. Diabetes Care,2001, 24:1093-1098. 被引量:1
  • 9Ziegler D, Mayer P, Rathmann W, et al. One-year treatmentwith the aldose reductase inhibitor, ponalrestat, in diabeticneuropathy. Diabetes Res Clin Pract, 1991,14:63-73. 被引量:1
  • 10Gingliano D, Marfella R,Quatraro A, et al. Tolrestat for milddiabetic neuropathy. A 52-week, randomized> placebo-con-trolled trial. Ann Intern Med, 1993,118:7-11. 被引量:1

共引文献50

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部